Rictor in Perivascular Adipose Tissue Controls Vascular Function by Regulating Inflammatory Molecule Expression

Objective—Perivascular adipose tissue (PVAT) wraps blood vessels and modulates vasoreactivity by secretion of vasoactive molecules. Mammalian target of rapamycin complex 2 (mTORC2) has been shown to control inflammation and is expressed in adipose tissue. In this study, we investigated whether adipose-specific deletion of rictor and thereby inactivation of mTORC2 in PVAT may modulate vascular function by increasing inflammation in PVAT. Approach and Results—Rictor, an essential mTORC2 component, was deleted specifically in mouse adipose tissue (rictorad−/−). Phosphorylation of mTORC2 downstream target Akt at Serine 473 was reduced in PVAT from rictorad−/− mice but unaffected in aortic tissue. Ex vivo functional analysis of thoracic aortae revealed increased contractions and impaired dilation in rings with PVAT from rictorad−/− mice. Adipose rictor knockout increased gene expression and protein release of interleukin-6, macrophage inflammatory protein-1&agr;, and tumor necrosis factor-&agr; in PVAT as shown by quantitative real-time polymerase chain reaction and Bioplex analysis for the cytokines in the conditioned media, respectively. Moreover, gene and protein expression of inducible nitric oxide synthase was upregulated without affecting macrophage infiltration in PVAT from rictorad−/− mice. Inhibition of inducible nitric oxide synthase normalized vascular reactivity in aortic rings from rictorad−/− mice with no effect in rictorfl/fl mice. Interestingly, in perivascular and epididymal adipose depots, high-fat diet feeding induced downregulation of rictor gene expression. Conclusions—Here, we identify mTORC2 as a critical regulator of PVAT-directed protection of normal vascular tone. Modulation of mTORC2 activity in adipose tissue may be a potential therapeutic approach for inflammation-related vascular damage.

[1]  B. Viollet,et al.  Perivascular Adipose Tissue Control of Insulin-Induced Vasoreactivity in Muscle Is Impaired in db/db Mice , 2013, Diabetes.

[2]  M. Yacoub,et al.  Adipose tissue: friend or foe? , 2012, Nature Reviews Cardiology.

[3]  M. Gollasch,et al.  Differential Effects of Cystathionine-γ-lyase–Dependent Vasodilatory H2S in Periadventitial Vasoregulation of Rat and Mouse Aortas , 2012, PloS one.

[4]  L. Guarente,et al.  High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. , 2012, Cell metabolism.

[5]  A. Heagerty,et al.  Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target , 2012, British journal of pharmacology.

[6]  R. Webb,et al.  Perivascular adipose tissue: more than just structural support. , 2012, Clinical science.

[7]  J. Suttles,et al.  Mammalian Target of Rapamycin Complex 2 (mTORC2) Negatively Regulates Toll-like Receptor 4-mediated Inflammatory Response via FoxO1* , 2011, The Journal of Biological Chemistry.

[8]  M. Czech,et al.  Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. , 2011, American journal of physiology. Heart and circulatory physiology.

[9]  J. Yeh,et al.  Role of Perivascular Adipose Tissue–Derived Methyl Palmitate in Vascular Tone Regulation and Pathogenesis of Hypertension , 2011, Circulation.

[10]  E. Jacinto,et al.  mTOR complex 2 signaling and functions , 2011, Cell cycle.

[11]  A. Heagerty,et al.  Macrophage Activation Is Responsible for Loss of Anticontractile Function in Inflamed Perivascular Fat , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Magnuson,et al.  Response to Comment on: Kumar et al. Fat Cell–Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism. Diabetes 2010;59:1397–1406 , 2011, Diabetes.

[13]  Ghada A. Soliman.  The integral role of mTOR in lipid metabolism , 2011, Cell cycle.

[14]  Ke Wang,et al.  Inhibition of iNOS protects endothelial-dependent vasodilation in aged rats , 2010, Acta Pharmacologica Sinica.

[15]  S. Shioda,et al.  Endovascular Injury Induces Rapid Phenotypic Changes in Perivascular Adipose Tissue , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[16]  E. Mervaala,et al.  Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[17]  M. Magnuson,et al.  Fat Cell–Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism , 2010, Diabetes.

[18]  E. Schiffrin,et al.  Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome , 2009, Hypertension.

[19]  Nadine Cybulski,et al.  TOR complex 2: a signaling pathway of its own. , 2009, Trends in biochemical sciences.

[20]  S. Kihara,et al.  Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling , 2009, Circulation research.

[21]  R. Charnigo,et al.  Obesity Promotes Inflammation in Periaortic Adipose Tissue and Angiotensin II–Induced Abdominal Aortic Aneurysm Formation , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[22]  J. Auwerx,et al.  mTOR complex 2 in adipose tissue negatively controls whole-body growth , 2009, Proceedings of the National Academy of Sciences.

[23]  R. M. Lee,et al.  Endothelium-dependent relaxation factor released by perivascular adipose tissue , 2009, Journal of hypertension.

[24]  Y. Zick,et al.  Phosphorylation of IRS proteins, insulin action, and insulin resistance. , 2009, American journal of physiology. Endocrinology and metabolism.

[25]  A. Heagerty,et al.  Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients , 2009, Circulation.

[26]  E. Dickson,et al.  Proinflammatory Phenotype of Perivascular Adipocytes: Influence of High-Fat Feeding , 2009, Circulation research.

[27]  F. Visseren,et al.  Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. , 2008, European heart journal.

[28]  T. Münzel,et al.  Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. , 2008, Journal of the American College of Cardiology.

[29]  C. Juan,et al.  Involvement of iNOS and NO in TNF‐α–downregulated Resistin Gene Expression in 3T3‐L1 Adipocytes , 2008, Obesity.

[30]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[31]  R. Ginnan,et al.  Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. , 2008, Free radical biology & medicine.

[32]  I. Bhattacharya,et al.  Regional Heterogeneity of Functional Changes in Conduit Arteries After High‐fat Diet , 2008, Obesity.

[33]  I. Bhattacharya,et al.  Endothelin stimulates vascular hydroxyl radical formation: effect of obesity. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[34]  M. Gollasch,et al.  Adiponectin is a novel humoral vasodilator. , 2007, Cardiovascular research.

[35]  R. M. Lee,et al.  Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide , 2007, British journal of pharmacology.

[36]  Seena K. Ajit,et al.  Use of a murine cell line for identification of human nitric oxide synthase inhibitors. , 2007, Journal of pharmacological and toxicological methods.

[37]  A. Ullrich,et al.  Endothelin‐1 inhibits adipogenesis: Role of phosphorylation of Akt and ERK1/2 , 2006, FEBS letters.

[38]  J. Woo,et al.  Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. , 2006, Developmental cell.

[39]  Arya M. Sharma,et al.  Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. , 2006, Cardiovascular research.

[40]  D. Sabatini,et al.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.

[41]  C. Stehouwer,et al.  “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease , 2005, The Lancet.

[42]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[43]  R. Loewith,et al.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.

[44]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[45]  J. Crespo,et al.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. , 2002, Molecular cell.

[46]  M. Gollasch,et al.  Periadventitial fat releases a vascular relaxing factor , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[48]  R. Brooks,et al.  NO-Dependent Vasorelaxation Is Impaired After Gene Transfer of Inducible NO-Synthase , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[49]  R. D. Rudic,et al.  Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. , 2000, The Journal of clinical investigation.

[50]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[51]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[52]  D. Harrison,et al.  Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[53]  Richard Graham Knowles,et al.  1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo* , 1997, The Journal of Biological Chemistry.

[54]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[55]  L. Cassis,et al.  Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. , 1991, Clinical and experimental hypertension. Part A, Theory and practice.